LabGenomics Launches New NGS Prenatal Test 'Mamguard Advance'... Registered with KDCA Items
LabGenomics announced on the 7th that it has completed the upgrade of its existing non-invasive prenatal test (NIPT), MomGuard, and has registered all newly added test items with the Korea Disease Control and Prevention Agency. Starting this December, it will officially provide the MomGuard Advance (Plus) testing service.
MomGuard is an NGS-based non-invasive prenatal screening test for fetal abnormalities, developed by LabGenomics as the first in the industry. Since its launch in 2014, the test service has been continuously upgraded by expanding test coverage, improving accuracy and speed, and providing highly readable results.
The company explained that MomGuard has been a key item driving LabGenomics' sales growth prior to the COVID-19 period. After five years, LabGenomics plans to start releasing new MomGuard products, upgrading existing services, and introducing new genetic tests.
The newly launched MomGuard offers three types?▲MomGuard, ▲MomGuard Advance, and ▲MomGuard Advance (Plus)?ranging from light to premium versions, thereby expanding options for expectant mothers.
In particular, the premium version, MomGuard Advance (Plus), has increased the number of sex chromosome aneuploidy tests (abnormal number of sex chromosomes) from three to four types and expanded the microdeletion and duplication items to up to 117, significantly enhancing cost-effectiveness. Additionally, it applies an algorithm developed in-house that distinguishes fetal DNA from maternal DNA, greatly reducing the false positive rate caused by the mother.
A company representative stated, “The newly applied algorithm utilizes the tendency that the length of fetal DNA is shorter than that of maternal DNA. By selectively analyzing only fetal DNA from the mother's blood, it significantly lowers the probability of false positives caused by maternal influence and demonstrates high accuracy.”
Hot Picks Today
"Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- "Sold Everything Fearing Bankruptcy, Then It Soared 3,900 Times: How a Stock Once Feared for Delisting Became an AI Powerhouse"
- "All Major Corporations Could Leave"... Business Community Fears Overseas Factory Relocation Due to Strike Risks
- Central Labor Relations Commission Chair: "Mediation Proposal Unlikely Today"... Second Post-Adjustment Talks Between Samsung Electronics Labor and Management Extended Until the 19th
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
They added, “As the key item that has driven LabGenomics' sales growth has been upgraded and released as a new product after five years, it is expected to lead to increased sales of MomGuard and other test items.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
